Obesity and type 2 diabetes

被引：268

作者：

Maggio, CA ^{[1
]}

Pi-Sunyer, FX ^{[1
]}

机构：

[1] Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Div Endocrinol Diabet & Nutr, New York, NY 10025 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2003年 / 32卷 / 04期

关键词：

D O I：

10.1016/S0889-8529(03)00071-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The increasing prevalence of obesity is accompanied by an increasing prevalence of type 2 diabetes. Obesity not only increases the risk of developing type 2 diabetes but also compounds its health risks and complicates its management. The health benefits of weight loss and the efficacy of current weight loss strategies in obese persons with type 2 diabetes are evaluated. In addition, the article reviews the results of lifestyle intervention trials designed to reduce conversion to type 2 diabetes in at-risk individuals.

引用

页码：805 / +

页数：19

共 82 条

[31] BENEFITS AND LIMITATIONS OF VERY-LOW-CALORIE DIET THERAPY IN OBESE NIDDM [J].

HENRY, RR ;

GUMBINER, B .

DIABETES CARE, 1991, 14 (09) :802-823

[32]

HOLBROOK TL, 1989, INT J OBESITY, V13, P723

[33] Role of orlistat in the treatment of obese patients with type 2 diabetes - A 1-year randomized double-blind study [J].

Hollander, PA ;

Elbein, SC ;

Hirsch, IB ;

Kelley, D ;

McGill, J ;

Taylor, T ;

Weiss, SR ;

Crockett, SE ;

Kaplan, RA ;

Comstock, J ;

Lucas, CP ;

Lodewick, PA ;

Canovatchel, W ;

Chung, J ;

Hauptman, J .

DIABETES CARE, 1998, 21 (08) :1288-1294

[34] TUMOR-NECROSIS-FACTOR-ALPHA - A KEY COMPONENT OF THE OBESITY-DIABETES LINK [J].

HOTAMISLIGIL, GS ;

SPIEGELMAN, BM .

DIABETES, 1994, 43 (11) :1271-1278

[35] Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. [J].

Hu, FB ;

Manson, JE ;

Stampfer, MJ ;

Colditz, G ;

Liu, S ;

Solomon, CG ;

Willett, WC .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) :790-797

[36] Experience with the Roux-en-Y gastric bypass, and commentary on current trends [J].

Jones, KB .

OBESITY SURGERY, 2000, 10 (02) :183-185

[37]

Kaufman FR, 2002, J PEDIATR ENDOCR MET, V15, P737

[38] Orlistat - In the prevention and treatment of type 2 diabetes mellitus [J].

Keating, GM ;

Jarvis, B .

DRUGS, 2001, 61 (14) :2107-2119

[39] Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes - A 1-year randomized controlled trial [J].

Kelley, DE ;

Bray, GA ;

Pi-Sunyer, FX ;

Klein, S ;

Hill, J ;

Miles, J ;

Hollander, P .

DIABETES CARE, 2002, 25 (06) :1033-1041

[40] RELATIVE EFFECTS OF CALORIE RESTRICTION AND WEIGHT-LOSS IN NONINSULIN-DEPENDENT DIABETES-MELLITUS [J].

KELLEY, DE ;

WING, R ;

BUONOCORE, C ;

STURIS, J ;

POLONSKY, K ;

FITZSIMMONS, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1287-1293

← 1 2 3 4 5 6 7 8 9 →